Meetings: Medicare Coverage Advisory Committee,

Text

---

Federal Register: December 13, 1999 (Volume 64, Number 238)NoticesPage 69538-69539From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr13de99-85

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Care Financing Administration

HCFA-3029-NMedicare Program; Meeting of the Medical and Surgical Procedures Panel of the Medicare Coverage Advisory Committee--January 19 and 20, 2000

AGENCY: Health Care Financing Administration (HCFA), HHS.

ACTION: Notice of meeting.

SUMMARY: This notice announces a public meeting of the Medical and Surgical Procedures Panel of the Medicare Coverage Advisory Committee (MCAC). The panel provides advice and recommendations to the agency about clinical coverage issues. The panel will hear and discuss presentations from interested persons regarding behavioral interventions (pelvic muscle rehabilitation) for the management of non- neurogenic urinary incontinence in adults. The meeting will primarily focus on two management options: biofeedback and pelvic floor electrical stimulation. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)).

DATES:

The Meeting: The meeting will be held on January 19, 2000 from 8:30 a.m. until 5 p.m., E.D.T., and on January 20, 2000, from 8:30 a.m. until 3:00 p.m., E.D.T.

[Page 69539]

Deadline for Presentations and Comments: You must submit formal presentations and written comments to the For Further Information Contact by December 29, 1999, 5 p.m., E.D.T.

Special Accommodations: Persons attending the meeting who are hearing or visually impaired and have special requirements, or a condition that requires special assistance or accommodations, are asked to notify the Executive Secretary by December 15, 1999.

ADDRESSES: The Meeting: The meeting will be held at the Baltimore Marriott Inner Harbor, 110 S. Eutaw Street, Baltimore, MD 21201.

Presentations and Comments: Submit formal presentations and written comments to Constance A. Conrad, Executive Secretary; Office of Clinical Standards and Quality; Health Care Financing Administration; 7500 Security Boulevard; Mail Stop S3-02-01; Baltimore, MD 21244.

Website: You may access up to date information on this meeting at www.hcfa.gov/quality/8b.htm.

FOR FURTHER INFORMATION CONTACT: Constance A. Conrad, Executive Secretary, 410-786-4631.

SUPPLEMENTARY INFORMATION: On August 13, 1999, we published a notice (64 FR 44231) to describe the MCAC, which provides advice and recommendations to us about clinical coverage issues. This notice announces the following public meeting of the MCAC:

Current Panel Members

Alan M. Garber, M.D.; Michael D. Maves, M.D.; Angus M. McBryde, M.D.; H. Logan Holtgrewe, M.D.; Kenneth P. Brin, M.D.; Les J. Zendle, M.D.; Bruce Sigsbee, M.D.; Linda D. Bradley, M.D.; James P. Rathmell, M.D.; Arnold M. Epstein, M.D.; Phyllis E. Greenberger, M.S.W.; Marshall S. Stanton, M.D.

Meeting Topic

The Panel will hear and discuss presentations from interested persons regarding behavioral interventions for the management of non- neurogenic urinary incontinence in adults. The meeting will primarily focus on two management options: biofeedback and pelvic floor electrical stimulation.

Procedure and Agenda

This meeting is open to the public. The panel will hear oral presentations from the public for approximately 2 hours and 30 minutes on the first day of the meeting. The Panel may limit the number and duration of oral presentations to the time available. It you wish to make formal presentations you must notify the For Further Information Contact, and submit the following by the Deadline for Presentations and Comments date listed in the Dates section of this notice: a brief statement of the general nature of the evidence or arguments you wish to present, the names and addresses of proposed participants, and an estimate of the time required to make the presentation. We will request that you declare at the meeting whether or not you have any financial involvement with manufacturers of any items or services being discussed (or with their competitors).

After the public presentation, we will make a presentation to the Panel. After our presentation, the Panel will deliberate openly on the topic. Interested persons may observe the deliberations, but the Panel will not hear further comments during this time except at the request of the chairperson. At the end of the Panel deliberations, the Panel will allow at least a 30-minute open public session for any attendee to address issues specific to the topic. After which, the members will vote and the panel will make its recommendation.

Authority: 5 U.S.C. App. 2, section 10(a)(1) and (a)(2).

(Catalog of Federal Domestic Assistance Program No. 93.774, Medicare--Supplementary Medical Insurance Program)

Dated: December 7, 1999. Jeffrey L. Kang, Director, Office of Clinical Standards and Quality, Health Care Financing Administration.

FR Doc. 99-32165Filed12-10-99; 8:45 amBILLING CODE 4120-01-U

---